Timothy A. Chan

6.8k total citations · 1 hit paper
13 papers, 2.2k citations indexed

About

Timothy A. Chan is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Timothy A. Chan has authored 13 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Timothy A. Chan's work include Glioma Diagnosis and Treatment (6 papers), Epigenetics and DNA Methylation (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Timothy A. Chan is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Epigenetics and DNA Methylation (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Timothy A. Chan collaborates with scholars based in United States, Netherlands and Hong Kong. Timothy A. Chan's co-authors include Luc G.T. Morris, Armida W. M. Fabius, Jason T. Huse, Şevin Turcan, Anuj Goenka, Patrick S. Ward, Olga A. Guryanova, Chao Lü, Emrullah Yilmaz and Logan A. Walsh and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Timothy A. Chan

12 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

2012 1.4k citations Şevin Turcan, Daniel Rohle et al. Nature profile →

Peers

Timothy A. Chan

MB

GENET

CR

ONCOL

PRM

Armida W. M. Fabius Netherlands

Olga A. Guryanova United States

Fonnet E. Bleeker Netherlands

Emrullah Yilmaz United States

Gaspar J. Kitange United States

Kenneth Aldape United States

Zhaoshi Bao China

Helena Carén Sweden

Nicholas M. Donin United States

Christine Toulas France

Armida W. M. Fabius Netherlands

Timothy A. Chan

1.5k ×1.0

MB

1.1k ×1.1

GENET

933 ×1.1

CR

370 ×1.0

ONCOL

305 ×1.0

PRM

Citations per year, relative to Timothy A. Chan Timothy A. Chan (= 1×) peers Armida W. M. Fabius

Countries citing papers authored by Timothy A. Chan

Since Specialization

Citations

This map shows the geographic impact of Timothy A. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy A. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy A. Chan more than expected).

Fields of papers citing papers by Timothy A. Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy A. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy A. Chan. The network helps show where Timothy A. Chan may publish in the future.

Co-authorship network of co-authors of Timothy A. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy A. Chan. A scholar is included among the top collaborators of Timothy A. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy A. Chan. Timothy A. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Jurić, Ivan, Emily E. Fink, Arvind Ravi, et al.. (2025). Single-cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathway. npj Precision Oncology. 9(1). 318–318.

2.

Pitter, Kenneth L., Dana L. Casey, Jeremy Setton, et al.. (2018). Pathogenic Mutations in ATM As Determinants of Local Control in Non-Small Cell Lung Cancers Treated with Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 102(3). S226–S226. 3 indexed citations

3.

Topalian, Suzanne L., Jedd D. Wolchok, Timothy A. Chan, et al.. (2015). Immunotherapy: The Path to Win the War on Cancer?. Cell. 161(2). 185–186. 81 indexed citations

4.

Peyser, Noah D., Yu Du, Hua Li, et al.. (2015). Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer. PLoS ONE. 10(8). e0135750–e0135750. 47 indexed citations

5.

Barker, Christopher A., Maria Chang, & Timothy A. Chan. (2014). Survival of patients treated with radiation therapy for anaplastic astrocytoma. Radiology and Oncology. 48(4). 381–386. 8 indexed citations

6.

Gerber, Naamit K., Anuj Goenka, Şevin Turcan, et al.. (2014). Transcriptional diversity of long-term glioblastoma survivors. Neuro-Oncology. 16(9). 1186–1195. 67 indexed citations

7.

Morris, Luc G.T. & Timothy A. Chan. (2014). Therapeutic targeting of tumor suppressor genes. Cancer. 121(9). 1357–1368. 120 indexed citations

8.

Fabius, Armida W. M., Wei Wu, Alicia Pedraza, et al.. (2014). Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis. Proceedings of the National Academy of Sciences. 111(22). 8149–8154. 72 indexed citations

9.

Spratt, Daniel E., Michael R. Folkert, Zachary S. Zumsteg, et al.. (2013). Temporal relationship of post-operative radiotherapy with temozolomide and oncologic outcome for glioblastoma. Journal of Neuro-Oncology. 116(2). 357–363. 39 indexed citations

10.

Barker, Christopher A., Andrew J. Bishop, Maria Chang, Kathryn Beal, & Timothy A. Chan. (2013). Valproic Acid Use During Radiation Therapy for Glioblastoma Associated With Improved Survival. International Journal of Radiation Oncology*Biology*Physics. 86(3). 504–509. 106 indexed citations

11.

Turcan, Şevin, Daniel Rohle, Anuj Goenka, et al.. (2012). IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature. 483(7390). 479–483. 1382 indexed citations breakdown →

12.

Barker, Christopher A., Kevin Camphausen, Philip J. Tofilon, & Timothy A. Chan. (2008). Outcome of Patients Undergoing Radiotherapy for High Grade Glioma While Taking the Histone Deacetylase Inhibitor, Valproic Acid. International Journal of Radiation Oncology*Biology*Physics. 72(1). S214–S214. 1 indexed citations

13.

Schuebel, Kornel E., Wei Chen, Leslie Cope, et al.. (2007). Comparing the DNA Hypermethylome with Gene Mutations in Human Colorectal Cancer. PLoS Genetics. 3(9). e157–e157. 275 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact